Zobrazeno 1 - 10
of 137
pro vyhledávání: '"M Boulton-Jones"'
Publikováno v:
Scottish Medical Journal. 49:14-17
Background: Exercise during dialysis (EDD) in End-Stage Renal Disease (ESRD) has been documented as an effective intervention to improving a patient's aerobic capacity. Aims: This pilot study aimed to confirm physiological improvements, to establish
Autor:
J G Douglas, D L Scott, A B Atkinson, A Dornhurst, Christopher J. Hawkey, Jones Dej., H Thurston, Scott Dgi., C W Pugh, John B. Eastwood, Jeremy Hughes, Joseph Elborn, Hill Avs., M. Fitzgerald, Christopher P. Conlon, J P Monson, Derek P. Jewell, A C Parker, Rawlins, A Wardlaw, Charles F. Gilks, R C Heading, John D. Isaacs, Jon S. Friedland, J H McKillop, C O Savage, C F George, R W Groves, D I Jodrell, Brian G. Williams, M J Kendall, Ell Rgg., Finlayson Ndc., R Jung, J. M. Boulton Jones, C S John, Jack Satsangi, Alan G. Jardine, Allan R, S Tomlinson, Connell Jmc., A P Weetman, Mark A. Vickers, P Price, G. Santis, M Whyte, Emad M. El-Omar, J H Lazarus, D A Heath, Adgey Aaj., P. J. T. Vallance, Graham A. MacGregor, C M Wiles, J C Petrie, Francesco P. Cappuccio, Axon Atr., J Ireland, M J Godman, Alistair S. Hall, R E Barry, P Beck, Seckl, E Hillhouse, G H Tomkin, David W. Ray, R W Stout, C C Evans
Publikováno v:
QJM. 94:643-656
Autor:
Kevin McLaughlin, Keith Simpson, R. A. Mactier, J. M. Boulton-Jones, Jonathan G. Fox, P Jerimiah
Publikováno v:
Nephrology Dialysis Transplantation. 13:1696-1701
BACKGROUND Over the past 14 years, important advances have been made in diagnosis and treatment of patients with pauci-immune necrotizing glomerulonephritis (PINGN). The present study set out to evaluate the impact of these advances on prognosis by c
Publikováno v:
QJM. 91:159-164
From 1986 to 1996, 53 patients with idiopathic membranous nephropathy (IMN) presented to the Glasgow Royal Infirmary renal unit: 19 (36%) were treated because of progressive disease. We compared outcomes of treated and untreated patients with 37 hist
Publikováno v:
Nephrology Dialysis Transplantation. 13:67-71
Introduction Background. The object of the study was to develop an artificial neural network (ANN ) to identify patients In the West of Scotland, 23% of patients with IgA with IgA nephropathy (IgAN ) with a poor prognosis nephropathy (IgAN ) will hav
Publikováno v:
QJM. 90:353-358
Diabetic nephropathy is a major cause of renal failure, accounting for 20% of patients starting dialysis. In clinical trials, effective blood-pressure control, especially by angiotensin-converting-enzyme inhibitors (ACEIs), retards the rate of progre
Publikováno v:
Scopus-Elsevier
Aims The aim of the present study was to determine how the pharmacokinetics of meloxicam are affected by kidney dysfunction and consequently to define the appropriate dose for the use of meloxicam in patients with mild or moderate renal impairment. M
Publikováno v:
Clinical Science. 87:421-425
1. Glomerular charge selectivity was assessed using the ratio of the clearance of pancreatic isoamylase to the clearance of the more anionic salivary isoamylase (CPAm/CSAm) in 53 patients with primary glomerulopathies (minimal change nephropathy, idi
Publikováno v:
Clinical Rheumatology. 12:327-331
This is a retrospective analysis of all patients with a raised titre of ANCA in a single centre over a two-year period. Sixty-five patients were identified and clinical data is presented for 58 of these — 34 male and 24 female. The median age is 56